INFECTOPHARM Arzneimittel und Consilium GmbH

Parasitic skin infections

Research activity includes clinical work in scabies, with emphasis on topical treatment options for controlling infestation and relieving skin symptoms.

  • Scabies treatment
  • Permethrin-based therapy
  • Topical antiparasitic care

The sponsor’s trial portfolio in this area reflects interest in improving management of contagious ectoparasitic skin disease.

Atopic dermatitis prevention

Clinical research also focuses on early prevention of atopic dermatitis in infants with a high familial risk, using skin care approaches aimed at supporting the skin barrier.

  • Infant skin barrier support
  • Atopic dermatitis risk reduction
  • Moisturizing skin care

This area centers on childhood dermatology and the prevention of chronic inflammatory skin disease.

Actinic keratosis

The sponsor funds studies in actinic keratosis, addressing treatment options for mild to moderate precancerous skin lesions associated with chronic sun damage.

  • Keratinocyte lesion therapy
  • Topical lesion management
  • Solar-induced skin disease

These trials show a clear interest in non-invasive dermatologic treatment for premalignant skin conditions.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Study on the Effectiveness of 5% Potassium Hydroxide Solution for Treating Mild to Moderate Actinic Keratosis in Adults

    Recruiting

    1 1
    Investigated diseases:
    Germany
  • Study on Scabies Treatment Comparing 10% Permethrin Cream to 5% Permethrin Cream for Patients with Scabies

    Recruiting

    1 1 1 1
    Investigated drugs:
    Germany
  • Study on Treating Scabies with Permethrin and Ivermectin for Patients with Scabies

    Recruiting

    1 1 1 1
    Investigated drugs:
    Germany
  • Study on Preventing Atopic Dermatitis in High-Risk Children Using Paraffin White Soft Cream

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Germany